2023 | Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial | Chan, A T C; Lee, V H F; RUEY-LONG HONG ; Ahn, M-J; Chong, W Q; Kim, S-B; Ho, G F; Caguioa, P B; Ngamphaiboon, N; Ho, C; Aziz, M A S A; Ng, Q S; Yen, C-J; Soparattanapaisarn, N; Ngan, R K-C; Kho, S K; Tiambeng, M L A; Yun, T; Sriuranpong, V; Algazi, A P; Cheng, A; Massarelli, E; Swaby, R F; Saraf, S; Yuan, J; Siu, L L | Annals of oncology : official journal of the European Society for Medical Oncology | 22 | 13 | |